
All patients with zzso zzso zzso pancreatic or head and neck zzso who initially benefit from zzso growth factor zzso zzso therapies eventually develop zzso An increasing understanding of the number and complexity of resistance mechanisms highlights the Herculean challenge of killing tumors that are resistant to zzso zzso Our growing knowledge of resistance pathways provides an opportunity to develop new zzso zzso and combination therapies to prevent or overcome therapeutic resistance in zzso We present a comprehensive review of resistance pathways to zzso therapies in zzso zzso and head and neck zzso and discuss therapeutic strategies that are designed to circumvent zzso 

